Reference
1. Verhamme K, Dieleman J, Bleumink G,
Van der Lei J, Sturkenboom M, Panel TPEE. Incidence and prevalence of
lower urinary tract symptoms suggestive of benign prostatic hyperplasia
in primary care—the Triumph project. European urology.
2002;42(4):323-8.
2. Andersson SO, Rashidkhani B,
Karlberg L, Wolk A, Johansson JE. Prevalence of lower urinary tract
symptoms in men aged 45–79 years: a population‐based study of 40 000
Swedish men. BJU international. 2004;94(3):327-31.
3. Malaeb BS, Yu X, McBean AM, Elliott
SP. National trends in surgical therapy for benign prostatic hyperplasia
in the United States (2000-2008). Urology. 2012;79(5):1111-7.
4. Stroup SP, Palazzi‐Churas K, Kopp
RP, Parsons JK. Trends in adverse events of benign prostatic hyperplasia
(BPH) in the USA, 1998 to 2008. BJU international. 2012;109(1):84-7.
5. Gravas S, Cornu J, Gacci M, et al.
Management of Non-neurogenic Male LUTS. EAU guidelines. 2020.
6. Han HH, Ko WJ, Yoo TK, et al.
Factors associated with continuing medical therapy after transurethral
resection of prostate. Urology. 2014;84(3):675-80.
7. Nitti VW, Kim Y, Combs AJ. Voiding
dysfunction following transurethral resection of the prostate: symptoms
and urodynamic findings. The Journal of urology. 1997;157(2):600-3.
8. Thomas AW, Cannon A, Bartlett E,
Ellis-Jones J, Abrams P. The natural history of lower urinary tract
dysfunction in men: minimum 10-year urodynamic followup of transurethral
resection of prostate for bladder outlet obstruction. The Journal of
urology. 2005;174(5):1887-91.
9. Hur WS, Kim JC, Kim HS, et al.
Predictors of urgency improvement after Holmium laser enucleation of the
prostate in men with benign prostatic hyperplasia. Investigative and
clinical urology. 2016 Nov;57(6):431-6. PubMed PMID: 27847917. Pubmed
Central PMCID: Pmc5109790. Epub 2016/11/17. eng.
10. Cho MC, Ha SB, Oh S-J, Kim SW,
Paick J-S. Change in storage symptoms following laser prostatectomy:
comparison between photoselective vaporization of the prostate (PVP) and
holmium laser enucleation of the prostate (HoLEP). World journal of
urology. 2015;33(8):1173-80.
11. Naspro R, Bachmann A, Gilling P,
et al. A review of the recent evidence (2006–2008) for 532-nm
photoselective laser vaporisation and holmium laser enucleation of the
prostate. European urology. 2009;55(6):1345-57.
12. Bostanci Y, Kazzazi A, Djavan B.
Laser prostatectomy: holmium laser enucleation and photoselective laser
vaporization of the prostate. Reviews in urology. 2013;15(1):1.
13. Cho MC, Kim HS, Lee CJ, Ku JH,
Kim SW, Paick JS. Influence of detrusor overactivity on storage symptoms
following potassium-titanyl-phosphate photoselective vaporization of the
prostate. Urology. 2010 Jun;75(6):1460-6. PubMed PMID: 19963247. Epub
2009/12/08. eng.
14. Foster HE, Dahm P, Kohler TS, et
al. Surgical management of lower urinary tract symptoms attributed to
benign prostatic hyperplasia: AUA Guideline Amendment 2019.
2019;202(3):592-8.
15. Abrams P, Cardozo L, Fall M, et
al. The standardisation of terminology in lower urinary tract function:
report from the standardisation sub-committee of the International
Continence Society. Urology. 2003;61(1):37-49.
16. Choi HR, Chung W, Shim BS, et al.
Translation Validity and Reliability of I-PSS Korean Version.
1996;37:659-65.
17. Weld KJ, Graney MJ, Dmochowski
RR. Differences in bladder compliance with time and associations of
bladder management with compliance in spinal cord injured patients. J
Urol. 2000 Apr;163(4):1228-33. PubMed PMID: 10737503. Epub 2000/03/29.
eng.
18. Harris RL, Cundiff GW,
Theofrastous JP, Bump RC. Bladder compliance in neurologically intact
women. Neurourology and Urodynamics: Official Journal of the
International Continence Society. 1996;15(5):483-8.
19. Bannowsky A, Wefer B, Braun PM,
Jünemann K-PJWjou. Urodynamic changes and response rates in patients
treated with permanent electrodes compared to conventional wire
electrodes in the peripheral nerve evaluation test. 2008;26(6):623-6.
20. Yu X, Elliott SP, Wilt TJ, McBean
AM. Practice patterns in benign prostatic hyperplasia surgical therapy:
the dramatic increase in minimally invasive technologies. The Journal of
urology. 2008;180(1):241-5.
21. Oelke M, Bachmann A, Descazeaud
A, et al. EAU guidelines on the treatment and follow-up of
non-neurogenic male lower urinary tract symptoms including benign
prostatic obstruction. European urology. 2013;64(1):118-40.
22. Siroky M. The aging bladder.
Reviews in urology. 2004;6(Suppl 1):S3.
23. Sullivan MP, Yalla SVJTJou.
Detrusor contractility and compliance characteristics in adult male
patients with obstructive and nonobstructive voiding dysfunction.
1996;155(6):1995-2000.
24. Yokoyama O, Mita E, Ishiura Y,
Nakamura Y, Nagano KL, Namiki M. Bladder compliance in patients with
benign prostatic hyperplasia. Neurourology and urodynamics.
1997;16(1):19-27.
25. Liao LM, Schaefer W.
Cross‐sectional and longitudinal studies on interaction between bladder
compliance and outflow obstruction in men with benign prostatic
hyperplasia. Asian journal of andrology. 2007;9(1):51-6.
26. Bellucci CH, Ribeiro WdO, Hemerly
TS, et al. Increased detrusor collagen is associated with detrusor
overactivity and decreased bladder compliance in men with benign
prostatic obstruction. Prostate international. 2017;5(2):70-4.
27. Akino H, Gobara M, Okada K.
Bladder dysfunction in patients with benign prostatic hyperplasia:
relevance of cystometry as prognostic indicator of the outcome after
prostatectomy. International journal of urology. 1996;3(6):441-7.
28. Kwon O, Lee H-E, Bae J, Oh JK, Oh
S-J. Effect of holmium laser enucleation of prostate on overactive
bladder symptoms and urodynamic parameters: a prospective study.
Urology. 2014;83(3):581-5.